REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
REATA PHARMACEUTICALS reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
REATA PHARMACEUTICALS reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, six executives at REATA PHARMACEUTICALS received on average a compensation package of $4.4M, a 523% increase compared to previous year.
Average pay of disclosed executives at REATA PHARMACEUTICALS
Manmeet S. Soni, Chief Financial Officer, received $13M in total. 92% of Soni's compensation, or $12M, was in option awards. Soni also received $409K in bonus, $530K in salary, as well as $70K in other compensation.
J. Warren Huff, Chief Executive Officer, received a compensation package of $5.5M, which increased by 493% compared to previous year. 78% of the compensation package, or $4.3M, was in option awards.
Colin J. Meyer, Chief Medical Officer, earned $2.2M in 2019, a 249% increase compared to previous year.
Jason D. Wilson, Executive Vice President, Operations, received $2M in 2019.
Michael D. Wortley, Chief Legal Officer, earned $2M in 2019.
Dawn C. Bir, Chief Commercial Officer and Executive Vice President, received $2M in 2019.
Related executives
J Huff
REATA PHARMACEUTICALS
Chief Executive Officer
Manmeet Soni
REATA PHARMACEUTICALS
Chief Financial Officer
Jason Wilson
REATA PHARMACEUTICALS
Executive Vice President, Operations
Dawn Bir
REATA PHARMACEUTICALS
Chief Commercial Officer and Executive Vice President
Colin Meyer
REATA PHARMACEUTICALS
Chief Innovation Officer and Executive Vice President
Michael Wortley
REATA PHARMACEUTICALS
Chief Legal Officer
You may also like
Source: SEC filing on April 29, 2020.